US Treasury proposes barring new US private investment in Chinese brain-computer interface companies

The US Treasury proposed rules on 22 October 2026 that would prohibit US persons from most new non-public investments in companies that develop or produce brain-computer interfaces and are based in, or owned or controlled from, China, Hong Kong or Macau. The definition covers invasive and non-invasive systems and their software. Brain-computer interfaces sit in the rule's prohibited tier, with no notify-only option, no technical threshold and no small-deal exemption for direct investments. Comments are due by 7 December 2026.

Industry News

Stanford launches a five-year project to build a digital twin of the human brain

Stanford's Wu Tsai Neurosciences Institute announced the Stanford Digital Brain Project on 2 November 2026, funded by Mark and Mary Stevens and Clara Wu Tsai, to train AI models that predict human brain activity from 7-tesla MRI and wearable MEG scans and release the data and models openly. A Meta-funded project of the same name, coordinated in Paris, scaled to $15 million in July.

Nov 4 · 4 min read

Market Moves

Chinese vision-implant maker Nanochap raises RMB 500 million

Hangzhou-based Nanochap Electronics said on 3 November 2026 that it had closed a RMB 500 million Series C+ round led by Gaorong Ventures, its second round of 2026, bringing its total funding to RMB 1 billion. The company is running a registration trial of a 320-channel retinal implant that it says has been placed in three blind patients.

Nov 4 · 3 min read

Market Moves

BrainCo is developing a brain-stimulation wearable it pitches as an electronic GLP-1

Hangzhou-based BrainCo is developing a wearable that it says could suppress appetite through brain stimulation, founding partner Nyx He told Bloomberg in an interview published on 3 November 2026, and aims to bring it to market within two to three years, starting in China. BrainCo has not named the device, given technical details or published any trial data.

Nov 4 · 4 min read

Industry News

Neuralink tests iPhone calls with its speech implant

Neuralink said on 29 October 2026 that its engineers spent 72 hours at the home of a participant in its VOICE speech trial and prototyped features including iPhone call integration, an iOS keyboard for brain-based dictation, lock-screen controls, automatic detection of attempted speech and a Grok agent triggered by thought. A Texas filing registered on 28 October shows Neuralink plans a $2.7 million vivarium at its Austin-area site.

Oct 31 · 4 min read

Industry News

Chinese state television says ultrasound brain stimulation improved conscious behaviour in 13 of 24 patients

China Central Television reported on 29 and 30 October 2026 that, in a study by the Shenzhen Institutes of Advanced Technology, part of the Chinese Academy of Sciences, and Kunming Medical University, 13 of 24 patients with chronic disorders of consciousness showed clear improvement after non-invasive ultrasound stimulation. Chinese media call the device a brain-computer interface, and the reports describe only stimulation. InsideBCI found no published paper on the study and no registration for it on ClinicalTrials.gov.

Oct 31 · 4 min read

Industry News

Precision Neuroscience signs Cleveland Clinic Abu Dhabi as its first research site outside the US

Precision Neuroscience signed a two-year memorandum of understanding with Cleveland Clinic Abu Dhabi on 21 October 2026, with the support of the Department of Health Abu Dhabi, to evaluate its Layer 7 cortical interface in collaborative clinical research. It is the company's first clinical research site outside the United States. The same hospital hosts Neuralink's UAE-PRIME trial, and Abu Dhabi's Mubadala Capital took part in Precision's $250 million Series D.

Oct 30 · 2 min read

Market Moves

NeuroXess raises RMB 700 million for its brain implant

Shanghai brain-computer interface company NeuroXess announced a RMB 700 million Series B round on 28 October 2026, co-led by SDIC Juli, Shenzhen Capital Group and Qinzhi Capital and described by 36Kr as dominated overall by state capital. The money will fund the multicentre registration trial of its implant for people with quadriplegia, a factory in Jiangxi and next-generation products.

Oct 29 · 4 min read